3C-like Proteinase

3C-like Proteinase 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • 종

    SARS-CoV-2 (1)

  • 태그

    His Tag (1)

  • 마커

    Unconjugated (1)

제품 번호종발현 시스템제품 설명단백질 구조순도특성
SARS-CoV-2
E. coli
SARS-CoV-2 3C-like Proteinase Protein, His Tag (active enzyme, MALS verified)
총 수량1
  • 1

3C-like Proteinase분자 배경

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
XKH-001(Xinkanghe Biomedical)XKH-001Phase 2 ClinicalSuzhou Kanova Biopharmaceutical Co Ltd, Beijing Kanova Biomedical Technology Co LtdAllergic asthma; Asthma; Inflammation
상세
  • 제품 목록
  • 임상 약물 정보